Skip to content
Disclosery

SECTORAL ASSET MANAGEMENT INC

Follow

13F filer, CIK 1274413, MONTREAL, Quebec, Canada

SECTORAL ASSET MANAGEMENT INC reported $143,303,475 across 82 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 39.65% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-26-096554

Period
2026-06-30
Reported value
$143M
Holdings
82
Top 10 weight
39.65%
New
15
Sold out
10

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ORKAnew+41,987$4M
DFTXnew+78,310$3.68M
IRTCnew+26,070$3.1M
AVTXnew+119,923$2.22M
SMMTadded+150,565$2.19M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
EVMNexited-589,005-$13.5M
GILDreduced-6,870-$868K
RAPPexited-25,421-$835K
VRTXreduced-1,575-$782K
BOLDexited-678,574-$746K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001104659-26-096554, largest first. % of portfolio is the value over $143,303,475, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 800,887 shares; 2024Q4: 800,787 shares; 2025Q1: 800,787 shares; 2025Q2: 800,787 shares; 2025Q3: 800,787 shares; 2025Q4: 800,787 shares; 2026Q1: 727,587 shares; 2026Q2: 727,587 shares 727,587$11.9M8.32%0Timeline
SISHOULDER INNOVATIONS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 430,282 shares; 2025Q4: 492,435 shares; 2026Q1: 430,407 shares; 2026Q2: 430,407 shares 430,407$8.73M6.09%0Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,996 shares; 2024Q4: 12,546 shares; 2025Q1: 9,416 shares; 2025Q2: 8,976 shares; 2025Q3: 9,376 shares; 2025Q4: 7,276 shares; 2026Q1: 6,354 shares; 2026Q2: 6,354 shares 6,354$7.62M5.32%0Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 13,125 shares; 2024Q4: 14,625 shares; 2025Q1: 12,895 shares; 2025Q2: 16,745 shares; 2025Q3: 13,545 shares; 2025Q4: 13,595 shares; 2026Q1: 14,957 shares; 2026Q2: 13,235 shares 13,235$5.5M3.84%-1,722Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 25,900 shares; 2024Q4: 22,900 shares; 2025Q1: 21,800 shares; 2025Q2: 19,300 shares; 2025Q3: 15,300 shares; 2025Q4: 20,300 shares; 2026Q1: 18,218 shares; 2026Q2: 18,218 shares 18,218$4.63M3.23%0Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 41,987 shares 41,987$4M2.79%newTimeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 13,155 shares; 2024Q4: 18,950 shares; 2025Q1: 17,175 shares; 2025Q2: 16,160 shares; 2025Q3: 17,660 shares; 2025Q4: 17,218 shares; 2026Q1: 22,164 shares; 2026Q2: 41,869 shares 41,869$3.9M2.72%+19,705Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 78,310 shares 78,310$3.68M2.57%newTimeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,700 shares; 2024Q4: not reported; 2025Q1: 15,000 shares; 2025Q2: 13,200 shares; 2025Q3: 20,700 shares; 2025Q4: 28,700 shares; 2026Q1: 23,231 shares; 2026Q2: 50,756 shares 50,756$3.42M2.39%+27,525Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 75,522 shares; 2024Q4: 69,552 shares; 2025Q1: 26,870 shares; 2025Q2: 257,270 shares; 2025Q3: 368,070 shares; 2025Q4: 56,945 shares; 2026Q1: 45,070 shares; 2026Q2: 110,870 shares 110,870$3.42M2.39%+65,800Timeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,090 shares; 2024Q4: 12,550 shares; 2025Q1: 10,385 shares; 2025Q2: 11,270 shares; 2025Q3: 10,340 shares; 2025Q4: 13,070 shares; 2026Q1: 9,210 shares; 2026Q2: 9,210 shares 9,210$3.34M2.33%0Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 26,700 shares; 2024Q4: 30,000 shares; 2025Q1: 69,240 shares; 2025Q2: 65,220 shares; 2025Q3: 74,070 shares; 2025Q4: 79,625 shares; 2026Q1: 69,615 shares; 2026Q2: 220,180 shares 220,180$3.21M2.24%+150,565Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 26,070 shares 26,070$3.1M2.16%newTimeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,800 shares; 2024Q4: 18,800 shares; 2025Q1: 14,800 shares; 2025Q2: 14,800 shares; 2025Q3: 14,800 shares; 2025Q4: 16,800 shares; 2026Q1: 12,200 shares; 2026Q2: 12,200 shares 12,200$3.07M2.14%0Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 24,000 shares; 2024Q4: 24,500 shares; 2025Q1: 26,900 shares; 2025Q2: 20,900 shares; 2025Q3: 16,400 shares; 2025Q4: 21,400 shares; 2026Q1: 21,480 shares; 2026Q2: 21,480 shares 21,480$2.77M1.94%0Timeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 10,090 shares; 2025Q2: 35,580 shares; 2025Q3: 39,235 shares; 2025Q4: 38,255 shares; 2026Q1: 30,013 shares; 2026Q2: 79,043 shares 79,043$2.75M1.92%+49,030Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,840 shares; 2024Q4: 3,670 shares; 2025Q1: 4,725 shares; 2025Q2: 6,945 shares; 2025Q3: 7,715 shares; 2025Q4: 8,005 shares; 2026Q1: 7,007 shares; 2026Q2: 5,432 shares 5,432$2.7M1.88%-1,575Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,997 shares; 2024Q4: 3,430 shares; 2025Q1: 3,103 shares; 2025Q2: 4,085 shares; 2025Q3: 3,890 shares; 2025Q4: 2,894 shares; 2026Q1: 3,564 shares; 2026Q2: 2,831 shares 2,831$2.63M1.83%-733Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 61,065 shares; 2024Q4: 51,310 shares; 2025Q1: 32,020 shares; 2025Q2: 19,690 shares; 2025Q3: 19,550 shares; 2025Q4: 17,885 shares; 2026Q1: 27,490 shares; 2026Q2: 20,620 shares 20,620$2.61M1.82%-6,870Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,681 shares; 2024Q4: 7,371 shares; 2025Q1: 15,230 shares; 2025Q2: 14,880 shares; 2025Q3: 13,425 shares; 2025Q4: 11,182 shares; 2026Q1: 19,668 shares; 2026Q2: 23,216 shares 23,216$2.48M1.73%+3,548Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 98,970 shares; 2025Q3: 192,770 shares; 2025Q4: 42,255 shares; 2026Q1: 19,059 shares; 2026Q2: 71,009 shares 71,009$2.44M1.7%+51,950Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,050 shares; 2024Q4: 3,050 shares; 2025Q1: 5,250 shares; 2025Q2: 5,250 shares; 2025Q3: 5,750 shares; 2025Q4: 4,850 shares; 2026Q1: 5,250 shares; 2026Q2: 5,850 shares 5,850$2.33M1.62%+600Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 332,270 shares; 2025Q3: 560,494 shares; 2025Q4: 63,015 shares; 2026Q1: 66,830 shares; 2026Q2: 224,928 shares 224,928$2.28M1.59%+158,098Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,450 shares; 2024Q4: 6,400 shares; 2025Q1: 6,100 shares; 2025Q2: 3,900 shares; 2025Q3: 4,300 shares; 2025Q4: 6,550 shares; 2026Q1: 5,874 shares; 2026Q2: 7,129 shares 7,129$2.25M1.57%+1,255Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 119,923 shares 119,923$2.22M1.55%newTimeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 121,300 shares 121,300$2.18M1.52%newTimeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 45,127 shares; 2024Q4: 34,500 shares; 2025Q1: 48,907 shares; 2025Q2: 50,007 shares; 2025Q3: 50,007 shares; 2025Q4: 45,347 shares; 2026Q1: 32,500 shares; 2026Q2: 61,100 shares 61,100$2.16M1.51%+28,600Timeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,600 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,307 shares; 2026Q2: 10,848 shares 10,848$2.1M1.46%+2,541Timeline
PLSEPULSE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 67,895 shares 67,895$1.88M1.31%newTimeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,775 shares; 2024Q4: 7,275 shares; 2025Q1: 10,575 shares; 2025Q2: 10,575 shares; 2025Q3: 10,575 shares; 2025Q4: 10,575 shares; 2026Q1: 9,597 shares; 2026Q2: 9,597 shares 9,597$1.83M1.28%0Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,250 shares; 2024Q4: 4,750 shares; 2025Q1: 3,250 shares; 2025Q2: 3,900 shares; 2025Q3: 3,900 shares; 2025Q4: 3,900 shares; 2026Q1: 3,508 shares; 2026Q2: 3,508 shares 3,508$1.76M1.23%0Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 19,398 shares; 2024Q4: 24,398 shares; 2025Q1: 18,698 shares; 2025Q2: 15,198 shares; 2025Q3: 17,198 shares; 2025Q4: 23,498 shares; 2026Q1: 25,578 shares; 2026Q2: 18,080 shares 18,080$1.64M1.14%-7,498Timeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 185,900 shares 185,900$1.61M1.12%newTimeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 33,026 shares; 2024Q4: 32,526 shares; 2025Q1: 24,226 shares; 2025Q2: 21,126 shares; 2025Q3: 22,126 shares; 2025Q4: 27,626 shares; 2026Q1: 34,780 shares; 2026Q2: 36,330 shares 36,330$1.55M1.08%+1,550Timeline
TMDXTRANSMEDICS GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 21,950 shares 21,950$1.46M1.02%newTimeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 28,593 shares; 2024Q4: 24,500 shares; 2025Q1: 18,068 shares; 2025Q2: 11,723 shares; 2025Q3: 10,223 shares; 2025Q4: 5,893 shares; 2026Q1: 7,300 shares; 2026Q2: 16,330 shares 16,330$1.39M0.97%+9,030Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,400 shares; 2024Q4: 3,400 shares; 2025Q1: 2,773 shares; 2025Q2: 2,773 shares; 2025Q3: 3,968 shares; 2025Q4: 3,715 shares; 2026Q1: 2,919 shares; 2026Q2: 2,169 shares 2,169$1.35M0.94%-750Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 25,500 shares; 2024Q4: 22,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,000 shares 13,000$1.34M0.94%newTimeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 25,850 shares; 2024Q4: 7,850 shares; 2025Q1: not reported; 2025Q2: 15,000 shares; 2025Q3: 15,000 shares; 2025Q4: 17,250 shares; 2026Q1: 17,338 shares; 2026Q2: 14,826 shares 14,826$1.34M0.94%-2,512Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 81,800 shares; 2025Q2: 134,150 shares; 2025Q3: 105,950 shares; 2025Q4: 84,255 shares; 2026Q1: 74,446 shares; 2026Q2: 65,596 shares 65,596$1.22M0.85%-8,850Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 50,000 shares; 2024Q4: 44,000 shares; 2025Q1: 19,500 shares; 2025Q2: 10,800 shares; 2025Q3: 10,800 shares; 2025Q4: not reported; 2026Q1: 21,150 shares; 2026Q2: 21,150 shares 21,150$1.22M0.85%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,428 shares; 2024Q4: 5,700 shares; 2025Q1: 28,348 shares; 2025Q2: 41,418 shares; 2025Q3: 30,188 shares; 2025Q4: 36,858 shares; 2026Q1: 25,573 shares; 2026Q2: 25,573 shares 25,573$1.1M0.77%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 84,400 shares; 2024Q4: 73,800 shares; 2025Q1: 79,020 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 32,685 shares; 2026Q1: 22,140 shares; 2026Q2: 26,740 shares 26,740$1.03M0.72%+4,600Timeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 29,350 shares; 2024Q4: 26,350 shares; 2025Q1: 23,850 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 11,100 shares; 2026Q2: 11,100 shares 11,100$876K0.61%0Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 11,300 shares; 2024Q4: 20,300 shares; 2025Q1: 17,250 shares; 2025Q2: 18,535 shares; 2025Q3: 18,405 shares; 2025Q4: 14,740 shares; 2026Q1: 11,272 shares; 2026Q2: 13,285 shares 13,285$836K0.58%+2,013Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 323,572 shares; 2025Q3: 395,872 shares; 2025Q4: 54,110 shares; 2026Q1: 71,480 shares; 2026Q2: 71,480 shares 71,480$784K0.55%0Timeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 12,500 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 12,000 shares 12,000$770K0.54%newTimeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,060 shares; 2024Q4: 595 shares; 2025Q1: 765 shares; 2025Q2: 765 shares; 2025Q3: 765 shares; 2025Q4: 1,723 shares; 2026Q1: 1,710 shares; 2026Q2: 1,370 shares 1,370$742K0.52%-340Timeline
HNGEHINGE HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 9,206 shares; 2025Q3: 11,206 shares; 2025Q4: 14,206 shares; 2026Q1: 12,244 shares; 2026Q2: 8,744 shares 8,744$726K0.51%-3,500Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 13,485 shares; 2026Q1: 10,851 shares; 2026Q2: 10,111 shares 10,111$706K0.49%-740Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,690 shares; 2024Q4: 8,300 shares; 2025Q1: 5,205 shares; 2025Q2: 3,323 shares; 2025Q3: 3,273 shares; 2025Q4: 2,990 shares; 2026Q1: 2,310 shares; 2026Q2: 2,310 shares 2,310$695K0.49%0Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,570 shares 2,570$685K0.48%newTimeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 114,650 shares; 2024Q4: 77,650 shares; 2025Q1: 59,650 shares; 2025Q2: 77,150 shares; 2025Q3: 77,150 shares; 2025Q4: 27,150 shares; 2026Q1: 27,500 shares; 2026Q2: 27,500 shares 27,500$662K0.46%0Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 122,394 shares; 2026Q2: 122,394 shares 122,394$624K0.44%0Timeline
PRVAPRIVIA HEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 52,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 36,500 shares; 2025Q4: 26,000 shares; 2026Q1: 27,136 shares; 2026Q2: 24,136 shares 24,136$621K0.43%-3,000Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,600 shares; 2024Q4: 5,800 shares; 2025Q1: 8,350 shares; 2025Q2: 8,535 shares; 2025Q3: 8,535 shares; 2025Q4: 7,715 shares; 2026Q1: 6,650 shares; 2026Q2: 7,470 shares 7,470$609K0.43%+820Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,440 shares; 2024Q4: 7,200 shares; 2025Q1: 9,440 shares; 2025Q2: 9,205 shares; 2025Q3: 9,205 shares; 2025Q4: 8,365 shares; 2026Q1: 7,200 shares; 2026Q2: 7,200 shares 7,200$571K0.4%0Timeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 43,500 shares; 2026Q2: 43,500 shares 43,500$565K0.39%0Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 36,870 shares; 2024Q4: 29,400 shares; 2025Q1: 23,530 shares; 2025Q2: 23,530 shares; 2025Q3: 25,030 shares; 2025Q4: 10,880 shares; 2026Q1: 9,450 shares; 2026Q2: 9,450 shares 9,450$541K0.38%0Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,637 shares; 2024Q4: 2,010 shares; 2025Q1: 2,927 shares; 2025Q2: 7,716 shares; 2025Q3: 7,201 shares; 2025Q4: 2,665 shares; 2026Q1: 1,870 shares; 2026Q2: 1,870 shares 1,870$533K0.37%0Timeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,181 shares; 2024Q4: 1,581 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,250 shares 1,250$497K0.35%newTimeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,274 shares; 2024Q4: 1,750 shares; 2025Q1: 2,274 shares; 2025Q2: 2,274 shares; 2025Q3: 2,244 shares; 2025Q4: 2,049 shares; 2026Q1: 1,750 shares; 2026Q2: 1,750 shares 1,750$422K0.29%0Timeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 16,430 shares; 2024Q4: 7,200 shares; 2025Q1: 9,280 shares; 2025Q2: 9,280 shares; 2025Q3: 9,280 shares; 2025Q4: 8,470 shares; 2026Q1: 7,200 shares; 2026Q2: 7,200 shares 7,200$404K0.28%0Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 6,027 shares; 2024Q4: 3,852 shares; 2025Q1: 2,855 shares; 2025Q2: 2,375 shares; 2025Q3: 2,375 shares; 2025Q4: 2,155 shares; 2026Q1: 1,850 shares; 2026Q2: 1,850 shares 1,850$400K0.28%0Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 329,513 shares; 2024Q4: 380,883 shares; 2025Q1: 370,513 shares; 2025Q2: 382,415 shares; 2025Q3: 33,885 shares; 2025Q4: 31,625 shares; 2026Q1: 31,618 shares; 2026Q2: 14,565 shares 14,565$393K0.27%-17,053Timeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,745 shares; 2024Q4: 4,370 shares; 2025Q1: 3,682 shares; 2025Q2: 2,782 shares; 2025Q3: 2,727 shares; 2025Q4: 2,472 shares; 2026Q1: 2,132 shares; 2026Q2: 2,132 shares 2,132$375K0.26%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 820 shares; 2025Q1: 1,020 shares; 2025Q2: 1,020 shares; 2025Q3: 1,020 shares; 2025Q4: 1,740 shares; 2026Q1: 1,500 shares; 2026Q2: 1,500 shares 1,500$367K0.26%0Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 63,300 shares; 2025Q3: 79,430 shares; 2025Q4: 61,200 shares; 2026Q1: 31,680 shares; 2026Q2: 15,680 shares 15,680$343K0.24%-16,000Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 6,430 shares; 2024Q4: 4,900 shares; 2025Q1: 6,240 shares; 2025Q2: 6,240 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,830 shares; 2026Q2: 1,830 shares 1,830$343K0.24%0Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,340 shares; 2026Q2: 2,340 shares 2,340$312K0.22%0Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,085 shares; 2024Q4: 11,500 shares; 2025Q1: 16,085 shares; 2025Q2: 16,085 shares; 2025Q3: 13,650 shares; 2025Q4: 11,170 shares; 2026Q1: 8,100 shares; 2026Q2: 4,100 shares 4,100$305K0.21%-4,000Timeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 13,960 shares; 2024Q4: 4,350 shares; 2025Q1: 5,600 shares; 2025Q2: 5,600 shares; 2025Q3: 5,600 shares; 2025Q4: 5,005 shares; 2026Q1: 4,350 shares; 2026Q2: 4,350 shares 4,350$305K0.21%0Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,980 shares; 2026Q2: 1,980 shares 1,980$297K0.21%0Timeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,500 shares; 2025Q1: 6,145 shares; 2025Q2: 6,060 shares; 2025Q3: 3,030 shares; 2025Q4: 2,750 shares; 2026Q1: 2,350 shares; 2026Q2: 2,350 shares 2,350$266K0.19%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 20,000 shares; 2025Q2: 231,485 shares; 2025Q3: 328,655 shares; 2025Q4: 22,480 shares; 2026Q1: 23,500 shares; 2026Q2: 23,500 shares 23,500$255K0.18%0Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 98,640 shares; 2024Q4: 106,007 shares; 2025Q1: 100,205 shares; 2025Q2: 65,785 shares; 2025Q3: 81,785 shares; 2025Q4: 29,803 shares; 2026Q1: 79,150 shares; 2026Q2: 29,900 shares 29,900$239K0.17%-49,250Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 24,395 shares; 2024Q4: 49,250 shares; 2025Q1: 33,695 shares; 2025Q2: 51,369 shares; 2025Q3: 221,872 shares; 2025Q4: 23,872 shares; 2026Q1: 14,102 shares; 2026Q2: 4,325 shares 4,325$232K0.16%-9,777Timeline
MEDPMEDPACE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,086 shares; 2024Q4: 830 shares; 2025Q1: 531 shares; 2025Q2: 531 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 430 shares; 2026Q2: 430 shares 430$228K0.16%0Timeline
TEMTEMPUS AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,160 shares; 2025Q2: 3,760 shares; 2025Q3: 3,760 shares; 2025Q4: 4,500 shares; 2026Q1: not reported; 2026Q2: 3,880 shares 3,880$225K0.16%newTimeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,000 shares 20,000$188K0.13%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 88,000 shares; 2026Q2: 88,000 shares 88,000$184K0.13%0Timeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 21,700 shares 21,700$37.5K0.03%newTimeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
EVMNEVOMMUNE INC589,005$13.5Mshares
RAPPRAPPORT THERAPEUTICS INC25,421$835Kshares
BOLDBOUNDLESS BIO INC678,574$746Kshares
ASNDASCENDIS PHARMA A/S2,800$728Kshares
QUREUNIQURE NV29,245$499Kshares
ALHCALIGNMENT HEALTHCARE INC26,911$474Kshares
RDNTRADNET INC7,999$447Kshares
INSPINSPIRE MED SYS INC7,225$373Kshares
NBIXNEUROCRINE BIOSCIENCES INC2,300$344Kshares
OMDAOMADA HEALTH INC25,620$322Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-096554 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001104659-26-096554 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001104659-26-062046 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001104659-26-011921 Quarter ended 2025-12-312026-02-09acceptance time not in the bulk data set
13F-HR 0001104659-25-112082 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001104659-25-078356 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001104659-25-049125 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001104659-25-013709 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001104659-24-118494 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001104659-24-088729 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR 0001104659-24-061089 Quarter ended 2024-03-312024-05-14acceptance time not in the bulk data set
13F-HR 0001104659-24-022582 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001104659-23-117467 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001104659-23-090436 Quarter ended 2023-06-302023-08-11acceptance time not in the bulk data set
13F-HR 0001104659-23-059619 Quarter ended 2023-03-312023-05-12acceptance time not in the bulk data set
13F-HR 0001104659-23-018063 Quarter ended 2022-12-312023-02-10acceptance time not in the bulk data set
13F-HR 0001104659-22-116875 Quarter ended 2022-09-302022-11-10acceptance time not in the bulk data set
13F-HR 0001104659-22-090800 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001104659-22-058211 Quarter ended 2022-03-312022-05-10acceptance time not in the bulk data set
13F-HR 0001104659-22-019952 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set
13F-HR 0001104659-21-138704 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001104659-21-105743 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001104659-21-066370 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0001104659-21-021495 Quarter ended 2020-12-312021-02-12acceptance time not in the bulk data set
13F-HR 0001104659-20-125051 Quarter ended 2020-09-302020-11-13acceptance time not in the bulk data set
13F-HR 0001104659-20-094408 Quarter ended 2020-06-302020-08-13acceptance time not in the bulk data set
13F-HR 0001104659-20-060525 Quarter ended 2020-03-312020-05-13acceptance time not in the bulk data set
13F-HR 0001104659-20-018421 Quarter ended 2019-12-312020-02-12acceptance time not in the bulk data set
13F-HR 0001104659-19-063907 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001104659-19-045891 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001104659-19-029204 Quarter ended 2019-03-312019-05-14acceptance time not in the bulk data set
13F-HR 0001104659-19-007490 Quarter ended 2018-12-312019-02-12acceptance time not in the bulk data set
13F-HR 0001104659-18-068465 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001104659-18-051494 Quarter ended 2018-06-302018-08-13acceptance time not in the bulk data set
13F-HR 0001104659-18-033268 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001104659-18-009094 Quarter ended 2017-12-312018-02-13acceptance time not in the bulk data set
13F-HR 0001104659-17-068399 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001104659-17-051739 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001104659-17-032751 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001104659-17-008034 Quarter ended 2016-12-312017-02-10acceptance time not in the bulk data set
13F-HR 0001104659-16-156249 Quarter ended 2016-09-302016-11-10acceptance time not in the bulk data set
13F-HR 0001104659-16-139204 Quarter ended 2016-06-302016-08-12acceptance time not in the bulk data set
13F-HR 0001104659-16-120779 Quarter ended 2016-03-312016-05-13acceptance time not in the bulk data set
13F-HR 0001104659-16-096363 Quarter ended 2015-12-312016-02-12acceptance time not in the bulk data set
13F-HR 0001104659-15-078664 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0001104659-15-059367 Quarter ended 2015-06-302015-08-13acceptance time not in the bulk data set
13F-HR 0001104659-15-038098 Quarter ended 2015-03-312015-05-14acceptance time not in the bulk data set
13F-HR 0001104659-15-010210 Quarter ended 2014-12-312015-02-13acceptance time not in the bulk data set
13F-HR 0001104659-14-080151 Quarter ended 2014-09-302014-11-13acceptance time not in the bulk data set
13F-HR 0001104659-14-061102 Quarter ended 2014-06-302014-08-14acceptance time not in the bulk data set
13F-HR 0001104659-14-038454 Quarter ended 2014-03-312014-05-14acceptance time not in the bulk data set
13F-HR 0001104659-14-008562 Quarter ended 2013-12-312014-02-12acceptance time not in the bulk data set
13F-HR 0001104659-13-083977 Quarter ended 2013-09-302013-11-13acceptance time not in the bulk data set
13F-HR 0001104659-13-062747 Quarter ended 2013-06-302013-08-12acceptance time not in the bulk data set